• Home
  • Media
  • Sitemap
  • About Us
    • The company
      • Brief Profile
      • Vision
      • Mission 2013
      • Key Milestones
      • Board of Directors
      • Key Management Team
    • Parabolic Drugs in News
    • Media Gallery
  •  Our Business
    • CRAMS
      • Infrastructure
      • Capabilities
      • Our Business Model
      • Why PDL?
      • Contact CRAMS Division
    • APIs
      • Segments
      • Manufacturing Facilities
      • Our Products
      • Accreditations
      • Contact us for APIs
    • R & D
      • R&D Centre, Barwala
      • R&D Lab, Derabassi
      • IPR,QA & QC
  •  Global Presence
    • Market Presence
    • Regulatory Affairs
    • Business Opportunities
      • Contract Research
      • Contract manufacturing
      • Strategic tieups for Global Marketing
  • Human Resources
    • HR at PDL
      • HR Vision
      • HR Goals
    • Work with us
      • Current Openings
      • Upload your CV
  • CSR
    • CSR Initiatives
    • Environmental Concern
    • Health and Safety
  • Investor Relations
    • MD's Address
    • Corporate Governance
    • Latest Financial Results
    • Key Financial Indicators
    • Shareholding Pattern
    • Annual Reports
    • Track PDL's Share
    • Contact IR
  • Contact us

Investor Relations and Financials

At Parabolic Drugs, the Investor Relations team functions in direction to meet every need of current and potential investor. It is a strategic function that integrates finance, corporate communication, and affairs thus empowering the best association with the financial investment institutions, Foreign Investors, Portfolio Managers and Investment Analysts amongst others


Visit Analyst Corner for Parabolic Drugs

 

 

 

 

 

 

 

Quick Links

Latest Financial Results

Key Financial Indicators

Download Annual Reports

Stock Track

Corporate Governance

Contact Investor Relation cell